Search

Divi's Laboratories

Sector: Healthcare | Industry: Drugs & Pharma
R 1,644.60 -7.35  | -0.44% 51.55% 32.43 43,871.34
NSE Price: Jul 18, 09:44 Change R    |  % 1-Year Change P/E Market Cap (R Cr)
NSE Jul 18, 09:44 1,644.60 -7.35 -0.44% 1,652.60 1,651.95 26,581 1,641.10 - 1,652.60
BSE Jul 18, 09:55 1,650.00 -2.60 -0.16% 1,655.95 1,652.60 1,178 1,641.60 - 1,655.95
Exchange & Time Last Price      Day Change Open Prev Close Volume    1-Day Range
SUBSCRIBE TO THE VALUE RESEARCH STOCK INSIGHT NEWSLETTER
6M Average Volume: 654,152 P/B: 6.31 NSE Code: DIVISLAB
52-Week Range: R 1,067.35 - 1,774.95 Dividend Yield: 0.61% BSE Code: 532488
TTM EPS: R 50.96 Book Value: R 262.07 Face Value: R 2
Number of stocks currently recommended as 'Buy' by Value Research Stock Advisor: 38
Price Graph
  • Sun Pharmaceutical Inds. (NSE)
  • S&P BSE 100


Please wait while we are fetching data...
Are you missing an opportunity to invest in great stocks at low valuations?
There are thousands of listed companies in India and yet only a handful that are worth investing at a particular time and at a particular price.

Our equity team has sifted through hundreds of companies and selected stocks that you should invest in. This list now has 38 stocks on it, and new ones are being added every month. Thousands of our members are using stagnant equity markets to buy great stocks at low prices. Membership of Value Research Stock Advisor is available at a 40% to 60% discount. Learn more and become a member
Performance
  YTD 1-Month 3-Month 1-Year 3-Year 5-Year 10-Year
Divi's Laboratories 11.42 7.23 -3.65 53.72 12.73 17.27 20.07
S&P BSE Sensex 8.73 0.65 -0.15 7.38 12.08 8.93 10.27
S&P BSE Healthcare -5.54 3.19 -9.43 -4.49 -6.43 2.11 13.45
Company's return has been calculated on basis of NSE's price.
As on Jul 17, 2019
Key Ratios
Revenue Per Share (R) Earnings Per Share (R) Return on Networth (%)


Please wait
while we are fetching data...


Please wait
while we are fetching data...


Please wait
while we are fetching data...
Annual Ratios (%)
  1-Year 3-Years 5-Years
Growth
Revenue -4.25 7.70 12.65
Net Profit -17.30 0.99 7.82
EPS -17.30 0.99 7.82
Book Value 10.59 19.24 18.83
Average
Operating Margin 35.36 37.65 38.94
Net Margin 21.90 25.53 26.65
Return on Networth 15.55 22.14 24.22
Return on Investment 21.68 28.67 31.02
Interim Growth Ratios (%)
  QoQ YoY YTD
Quarterly
Revenue -6.44 15.49 15.49
Operating Profit -18.83 4.18 4.18
Net Profit -23.75 10.61 10.61
EPS -23.75 10.61 10.61
TTM
Revenue 3.58 27.17 27.17
Operating Profit 0.91 47.13 47.13
Net Profit 2.13 53.25 53.25
EPS 2.13 53.25 53.25
Peer Comparison
  Market Cap
(R Cr)
Revenue
(R Cr)
Net Profit
(R Cr)
Net Margin (%) RoE (%) Price to Book Price to Earnings
Divi's Laboratories 43,871.34 4,879.66 1,332.65 26.21 15.55 6.31 32.43
Cipla 44,916.88 16,362.41 1,509.61 8.96 10.65 2.99 29.40
Sun Pharmaceutical Inds. 103,159.41 29,065.91 3,185.32 10.59 7.05 2.49 38.70
Insider Trades
Date Person  Buy / Sell Transaction
Type
No of Shares Price
(R)   
Value
(R Lakhs)
Jul 09, 2019 Sridhar Donepudi  Sell Market 558 1,605.10 8.96
Mar 19, 2019 Madhusudana Rao Divi  Sell Market 1,000 1,696.00 16.96
Mar 16, 2019 N Chandrika Ramana  Sell Market 16,585 1,708.00 283.27
Mar 16, 2019 N Chandrika Ramana  Sell Market 3,415 1,708.00 58.33
Feb 13, 2019 K CHANDRA RAO  Buy Market 1,500 1,639.10 24.59
Fund Houses invested in the stock
Fund Jun-19 Mar-19 Dec-18 Sep-18 Jun-18
SBI Mutual Fund 4.343 4.540 4.662 4.889 4.628
Reliance Mutual Fund 2.695 2.897 3.298 3.575 3.946
Axis Mutual Fund 1.743 1.573 1.301 1.415 1.344
Mirae Asset Mutual Fund 1.141 0.884 1.033 0.880 0.326
HDFC Mutual Fund 0.870 0.853 0.860 0.868 0.857
DSP Mutual Fund 0.740 0.647 0.616 1.020 1.382
UTI Mutual Fund 0.724 0.699 0.659 0.660 0.714
L&T Mutual Fund 0.579 0.712 0.845 1.250 1.278
Canara Robeco Mutual Fund 0.507 0.356 0.334 0.487 0.004
Kotak Mahindra Mutual Fund 0.377 0.328 0.157 0.268 0.353
Figures given above are % of equity capital
Review & Analysis
News & Announcements
Contact Information

Company: Divi's Laboratories Ltd.

Address: 1-72/23(p)/divis/303, Divi Towers, Cyber Hills, Gachibowli, Hyderabad, Telangana - 500032 | Phone: 040 2378 6300 | Fax: 040 2378 6460

Email: [email protected]

Website: www.divislaboratories.com

Registrar & Transfer Agent: Karvy Fintech Pvt Ltd.-(Karvy Computuershare Pvt Ltd.)

Address: Karvy Selenium Tower B, Plot 31-32Gachibowli,Financial District, NanakramgudaHyderabad – 500032Tel. No. 040 67161500Fax. No. 040 23001153E-mail: [email protected]: www.karvy.comToll Free No. of exclusive Call Centre:1-800-345001, Karvy Selenium Tower B, Plot 31-32, Gachibowli,Financial District, Nanakramguda | Phone: 91-040-67161500 | Fax: 91-040-23001153

Email: [email protected]

Website: www.karvy.com

comments powered by Disqus
Essential checks
Altman Z-Score
13.36
Piotroski F-Score
4
Modified C-Score
4
5-Years Price to Earnings
32.43
5-Years Price to Book
6.31
Earnings Yield
EBIT / Enterprise value
2.94%
PEG
Price / Earnings to growth ratio
4.15
Related Stocks
  Current Price   Chng %
Aurobindo Pharma R575.00 +0.32%
Biocon R263.00 +0.04%
Cadila Healthcare R240.75 -0.04%
Cipla R553.50 -0.73%
Dr. Reddy's Lab R2,645.00 -0.80%
Glaxosmithkline Pharma R1,184.95 +0.05%
Lupin R765.70 -0.81%
Piramal Enterprises R2,019.00 -1.84%
Sun Pharmaceutical Inds. R426.15 -0.91%
Torrent Pharmaceuticals R1,536.35 -3.11%
As on Jul 18, 09:44